Evidence map›Paper›PMID 12065516›Full record

ArticleInfection and immunity2002

Glycoinositolphospholipids from Trypanosoma cruzi interfere with macrophages and dendritic cell responses.

Claudia Brodskyn, Julie Patricio, Rubem Oliveira, Lucas Lobo, Andrea Arnholdt, Lucia Mendonça-Previato, Aldina Barral, Manoel Barral-Netto

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 78 citations in OpenAlex.

  1. Review
  2. Free GPIs and Comparison of GPI Structures Among Species.International journal of molecular sciences · 2025
    Review
  3. Towards a map of the immune system manipulation network byFrontiers in cellular and infection microbiology · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Specific activation of CD4Clinical and experimental immunology · 2017
    Article
  11. Response toFrontiers in microbiology · 2017
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Claudia BrodskynCentro de Pesquisa Gonçalo Moniz, FIOCRUZ, Instituto de Ciências da Saúde, Universidade Federal Bahia, Salvador, Brazil.
Julie Patricio
Rubem Oliveira
Lucas Lobo
Andrea Arnholdt
Lucia Mendonça-Previato
Aldina Barral
Manoel Barral-Netto
Universidade Federal da Bahia · BRFundação Oswaldo Cruz · BRInstituto de Saúde · BRState University of Norte Fluminense · BRUniversidade Federal do Rio de Janeiro · BR

Funding

The role of Leishmania braziliensis strain polymorphism on disease outcome and ..P50AI030639 · NIAID · FEDERAL UNIVERSITY OF BAHIA · PI CARVALHO, EDGAR M · 1991 to 2023
$9.1M
NIAID NIH HHS AI 30639NIAID NIH HHS P50 AI030639
6 · The paper itself

Abstract

To investigate the possible effects of glycoinositolphospholipid (GIPL) from Trypanosoma cruzi on human antigen presenting cells, we tested their effects on lipopolysaccharide (LPS)-stimulated human macrophages and dendritic cells (DC). Human macrophages or DC were incubated with GIPL (50 microg/ml) and LPS (500 pg/ml) and tumor necrosis factor alpha (TNF-alpha), interleukin 8 (IL-8), IL-10, and IL-12p40 levels in supernatants were analyzed by enzyme-linked immunosorbent assay. TNF-alpha, IL-10, and IL-12 secretion were significantly decreased by GIPL both in macrophages and DC. In contrast, GIPL did not alter IL-8 production. We also analyzed the expression of CD80, CD86, HLA-DR, CD40, and CD57 on the macrophage surface after stimulation with LPS in the presence or absence of T. cruzi GIPL. GIPL led to a down-regulation in the expression of all tested molecules. We additionally examined the influence of T. cruzi GIPL on the response of human DC to LPS. LPS-induced HLA-DR, CD83, and CD86 up-regulation was significantly inhibited by GIPL. A slight down-regulation in CD80 and CD40 expression on DC surfaces in the presence of GIPL was also noticed. Similarly, GIPL led to down-modulation of CD83, CD80, CD86, and HLA-DR surface expression and TNF-alpha and IL-10 production when DC were stimulated by CD40L. The ceramide portion of GIPL was responsible for most of the activity exhibited by the whole molecule. Considering the important role of the immune response in determining the fate of the host-parasite relationship, the immunoregulatory activities of T. cruzi GIPL are potentially important for parasite evasion and then pathogenesis of infection with protozoan parasites.

Indexed as

AnimalsAntigens, CDB7-1 AntigenB7-2 AntigenCells, CulturedCeramidesDendritic CellsGlycolipidsHLA-DR AntigensHumansIntercellular Adhesion Molecule-1Interleukin-10Interleukin-12Interleukin-8LipopolysaccharidesMacrophagesAntigens, CDB7-1 AntigenB7-2 AntigenCD86 protein, humanCeramidesglycoinositolphospholipid, TrypanosomaGlycolipidsHLA-DR AntigensIntercellular Adhesion Molecule-1Interleukin-10Interleukin-12Interleukin-8LipopolysaccharidesMembrane GlycoproteinsPhospholipidsTumor Necrosis Factor-alpha

Identifiers

PMID12065516
PMCPMC128086
OpenAlexW2145152273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.